APA (7th ed.) Citation

Choderlos de Laclos, X., Risbourg, S., Brennan, B., Bertucci, F., Gaspar, N., Gelderblom, H., . . . Gandemer, V. (2024). Impact of age on safety of Busulfan-Melphalan followed by autologous hematopoietic stem-cell transplantation versus standard chemotherapy in the patients of the EURO-E.W.I.N.G. 99 and Ewing 2008 clinical trials. European journal of cancer, 208, . https://doi.org/10.1016/j.ejca.2024.114229

Chicago Style (17th ed.) Citation

Choderlos de Laclos, Xavier, et al. "Impact of Age on Safety of Busulfan-Melphalan Followed by Autologous Hematopoietic Stem-cell Transplantation Versus Standard Chemotherapy in the Patients of the EURO-E.W.I.N.G. 99 and Ewing 2008 Clinical Trials." European Journal of Cancer 208 (2024). https://doi.org/10.1016/j.ejca.2024.114229.

MLA (9th ed.) Citation

Choderlos de Laclos, Xavier, et al. "Impact of Age on Safety of Busulfan-Melphalan Followed by Autologous Hematopoietic Stem-cell Transplantation Versus Standard Chemotherapy in the Patients of the EURO-E.W.I.N.G. 99 and Ewing 2008 Clinical Trials." European Journal of Cancer, vol. 208, 2024, https://doi.org/10.1016/j.ejca.2024.114229.